Find uplifting stories about heroes, innovations, and solutions
10 results for "leukemia treatment"
A husband-and-wife research team turned their midnight lab conversations at the University of Virginia into ziftomenib, a newly FDA-approved drug now saving lives of leukemia patients who had run out of options. Their 17-year journey from academic research to life-saving treatment shows how university labs can tackle diseases others overlook.
Chinese scientists created a simple add-on that makes failing cancer treatments work again, without expensive genetic engineering. Patients who relapsed after CAR T therapy could now get a second chance at survival.
A breakthrough combination therapy is giving aggressive leukemia patients new hope, nearly doubling remission rates and opening the door to life-saving transplants. The treatment developed in Germany could soon become the new standard of care.
When Britt Mayo was diagnosed with leukemia in 2010, one conversation about his life priorities helped him avoid chemotherapy and qualify for a trial that led to remission. Now he's helping other patients learn they have choices in their cancer care.
Scientists in China have discovered how to turn a single stem cell into 14 million powerful cancer fighters, potentially making lifesaving treatment available to thousands more patients. The breakthrough slashes costs and could transform how we treat leukemia and other cancers.
Researchers at Monash University have found a way to permanently silence cancer-causing genes in aggressive leukemias, potentially allowing shorter treatment courses with fewer side effects. The discovery targets the cellular "memory" that keeps cancer genes switched on.
Researchers developed a breakthrough method to systematically create molecular glues that destroy disease-causing proteins, transforming leukemia treatment and opening doors to tackle previously untreatable diseases. What was once a game of chance is now a precise science.
Scientists discovered how to permanently switch off cancer-causing genes, potentially shortening treatment and reducing harsh side effects. The breakthrough targets aggressive leukemia and enters clinical trials this year.
Young leukemia patients are beating cancer at remarkable rates thanks to a groundbreaking Australian treatment that swaps harsh chemo for immune therapy. Nearly 9 in 10 patients remain cancer-free three years later.
Researchers at Indiana University discovered a critical vulnerability in acute myeloid leukemia that could transform treatment for a cancer with just a 33% five-year survival rate. Their breakthrough targets the inflammatory pathway that helps cancer stem cells survive chemotherapy and cause relapse.